This inventor holds 1 USPTO granted patent. Top assignee: Inflazome Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovator Spotlight: Paul Leeson
Introduction: Paul Leeson, based in Leicestershire, GB, is an accomplished inventor known for his contributions to the pharmaceutical field. With a keen focus on chemical compounds, Leeson's work aims to enhance medical treatments and improve health outcomes for patients.
Latest Patents: Paul Leeson holds a patent related to novel compounds, referred to in his innovation as formula (I). These compounds encompass a range of structures wherein Q can be O or S, and R depicts a hydrocarbyl group that may be straight-chained, branched, or cyclic. The invention also explores the various substitutions available for these hydrocarbyl groups and their potential therapeutic applications. Notably, the compounds described may exist as salts, solvates, or prodrugs, and they are particularly significant in treating and preventing medical disorders by inhibiting NLRP.
Career Highlights: Paul is currently employed at Inflazome Limited, a forward-thinking company that specializes in revolutionary medical solutions. His research and innovation in the field of pharmaceuticals have positioned him as a notable contributor to advancements in treatment methodologies.
Collaborations: In his pursuit of innovation, Paul collaborates with talented individuals, including coworkers David Miller and Stephen Thom. These partnerships foster a creative and productive environment, where ideas can flourish into groundbreaking solutions.
Conclusion: Paul Leeson exemplifies the spirit of innovation through his patented compounds and collaborative efforts at Inflazome Limited. His work not only highlights the importance of research and development in pharmaceuticals but also serves as an inspiration for future inventors aiming to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile